Key Summary
- A batch of Ramipril 5 mg was recalled after packs were found containing Amlodipine tablets by mistake.
- Anyone with the affected batch should check their pack and return it to a pharmacist.
- Health officials say the risk is low, but patients with side effects should seek medical advice.
Crescent Pharma is recalling a batch of Ramipril 5 mg capsules following a packaging error complaint.
A pharmacy had lodged a complaint after a patient reported that a pack labelled Ramipril 5 mg Capsules (Batch Number GR164099) contained blister strips of Amlodipine 5 mg Tablets inside the sealed carton.
Both the blood pressure medications are manufactured by Crescent Pharma and at the same site.
Patients who take Ramipril and received the above-mentioned batch are advised to check the packaging of their medicine and return any containing blister strips labelled “Amlodipine” to their pharmacist.
As both are used to treat high blood pressure, the risk to patients because of the accidental substitution is low. The most likely side effect would be dizziness related to low blood pressure.
The Medicines and Healthcare products Regulatory Agency (MHRA) states that the error might have happened during the secondary packaging.
Deputy director, Benefit-Risk Evaluation at the MHRA, Shareen Doak said, “If you have an affected pack and think you may have taken the Amlodipine 5 mg Tablets that were supplied in error, and you are currently experiencing any side effects, then please seek immediate medical advice.”
